Literature for ramipril (XM02.001 inhibitor)

(Topics flags: I Inhibitor. To select only the references relevant to a single topic, click the link above. See explanation.)

2013
1. Gomez,C., Berteina-Raboin,S., de Nanteuil,G. and Guillaumet,G.
   Perindopril and ramipril phosphonate analogues as a new class of angiotensin converting enzyme inhibitors
   Bioorg Med Chem21, 7216-7221. PubMed  Europe PubMed DOI  I
1996
2. Deddish,P.A., Wang,L.X., Jackman,H.L., Michel,B., Wang,J., Skidgel,R.A. and Erdos,E.G.
   Single-domain angiotensin I converting enzyme (kininase II): characterization and properties
   J Pharmacol Exp Ther279, 1582-1589. PubMed  Europe PubMed  I
1992
3. Hooper,N.M., Hryszko,J., Oppong,S.Y. and Turner,A.J.
   Inhibition by converting enzyme inhibitors of pig kidney aminopeptidase P
   Hypertension19, 281-285. PubMed  Europe PubMed  I
1987
4. Bunning,P.
   Kinetic properties of the angiotensin converting enzyme inhibitor ramiprilat
   J Cardiovasc Pharmacol10 Suppl 7, S31-S35. PubMed  Europe PubMed  I
1985
5. [YEAR:10-3-1985]Bull,H.G., Thornberry,N.A., Cordes,M.H., Patchett,A.A. and Cordes,E.H.
   Inhibition of rabbit lung angiotensin-converting enzyme by N alpha-[(S)-1-carboxy-3-phenylpropyl]L-alanyl-L-proline and N alpha-[(S)-1-carboxy-3-phenylpropyl]L-lysyl-L-proline
   J Biol Chem260, 2952-2962. PubMed  Europe PubMed  I
1984
6. Bunning,P.
   Inhibition of angiotensin converting enzyme by 2-[N-[(S)-1-carboxy-3-phenylpropyl]-L-alanyl]-(1S,3S,5S)-2-azabicyclo [3.3.0]octane-3-carboxylic acid (Hoe 498 diacid). Comparison with captopril and enalaprilat
   Arzneimittelforschung34, 1406-1410. PubMed  Europe PubMed  I